A A A

GET IN TOUCH

Technology & Screenings

Diseases

Our Expertise

Treatments

CLINICAL TRIALS - CURRENTLY RECRUITING PATIENTS
BOOK A CONSULATION

Publications

  1. Cehajic-Kapetanovic J, Xue K, Martinez-Fernandez de la Camara C, Nanda A, Davies A, Wood LJ, Salvetti AP, Dominik Fischer M, Aylward JW, Barnard AR, Jolly JK, Luo E, Girach A, Black GCM, Gregori NZ, Davis JL, Rosa PR, Lotery AJ, Lam BL, Stanga PE, MacLaren RE. Gene therapy in X-linked retinitis pigmentosa caused by mutations in RPGR: Results at 6 months in a first in human clinical trial. Accepted and In Press Nature Medicine submission NMED-L97396E.
  2. Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Rachitskaya A, Yuan A, Jayasundera KT, Zacks DN, Handa JT, Montezuma SR, Koozekanani D, Stanga PE, da Cruz L, Walter P, Augustin AJ, Chizzolini M, Olmos de Koo LC, Ho AC, Kirchhof B, Hahn P, Vajzovic L, Iezzi R Jr, Gaucher D, Arevalo JF, Gregori NZ, Grisanti S, Özmert E, Yoon YH, Kokame GT, Lim JI, Szurman P, de Juan E Jr, Rezende FA, Salzmann J, Richard G, Huang SS, Merlini F, Patel U, Cruz C, Greenberg RJ, Justus S, Cinelli L, Humayun MS. ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion. Retina. 2020 Feb;40(2):303-311.
  3. Choudhry N, Duker JS, Freund KB, Kiss S, Querques G, Rosen R, Sarraf D, Souied EH, Stanga PE, Staurenghi G, Sadda SR. Classification and Guidelines for Widefield Imaging: Recommendations from the International Widefield Imaging Study Group. Ophthalmol Retina. 2019 Oct;3(10):843-849
  4. Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Rachitskaya A, Yuan A, Jayasundera KT, Zacks DN, Handa JT, Montezuma SR, Koozekanani D, Stanga P, da Cruz L, Walter P, Augustin AJ, Olmos de Koo LC, Ho AC, Kirchhof B, Hahn P, Vajzovic L, Iezzi R, Gaucher D, Arevalo JF, Gregori NZ, Wiedemann P, Özmert E, Lim JI, Rezende FA, Huang SS, Merlini F, Patel U, Greenberg RJ, Justus S, Bacherini D, Cinelli L, Humayun MS. Hypotony and the Argus II retinal prosthesis: causes, prevention and management. Br J Ophthalmol. 2019 Jul 12. pii: bjophthalmol-2019-314135. doi: 10.1136/bjophthalmol-2019-314135. [Epub ahead of print]
  5. Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Rachitskaya A, Yuan A, Jayasundera KT, Zacks DN, Handa JT, Montezuma SR, Koozekanani D, Stanga PE, da Cruz L, Walter P, Augustin AJ, Chizzolini M, Olmos de Koo LC, Ho AC, Kirchhof B, Hahn P, Vajzovic L, Iezzi R Jr, Gaucher D, Arevalo JF, Gregori NZ, Grisanti S, Özmert E, Yoon YH, Kokame GT, Lim JI, Szurman P, de Juan E Jr, Rezende FA, Salzmann J, Richard G, Huang SS, Merlini F, Patel U, Cruz C, Greenberg RJ, Justus S, Cinelli L, Humayun MS. Adverse events of the Argus II retinal prosthesis: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion. Retina. 2018 Nov 20. doi: 10.1097/IAE.0000000000002394. [Epub ahead of print]
  6. Stanga PE, Williams JI, Shaarawy SA, Agarwal A, Venkataraman A, Kumar DA, You TT, Hope RS. First-in-human clinical study to investigate the effectiveness and safety of pars plana vitrectomy surgery using a new hypersonic technology. Retina. 2018 Oct 23. doi: 10.1097/IAE.0000000000002365. [Epub ahead of print]
  7. Ch’ng SW, Papayannis A, Stringa F, Tsamis E, Stanga P, Jalil A. The effect of bevacizumab before vitrectomy for diabetic tractional retinal detachment demonstrated on optical coherence tomography angiography. J Curr Ophthalmol. 2018 Jun 21;30(3):276-279
  8. Romano F, Arrigo A, Chʼng SW, Battaglia Parodi M, Manitto MP, Martina E, Bandello F, Stanga PE. CAPILLARY NETWORK ALTERATIONS IN X-LINKED RETINOSCHISIS IMAGED ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina. 2018 Jun 5. doi: 10.1097/IAE.0000000000002222. [Epub ahead of print]
  9. Ch’ng SW, Irion LD, Bonshek R, Shaw J, Papayannis A, Pastor-Idoate S, Stanga PE. Live porcine thirty days delayed recovery surgery: Qualitative findings with the hypersonic vitrectomy. PLoS One. 2018 Jun 1;13(6):e0197038. doi: 10.1371/journal.pone.0197038. eCollection 2018
  10. Stanga PE, Romano F, Chwiejczak K, Tsamis E, Stringa F, Biswas S, Bento G, Arrigo A, Parodi MB, Bandello F. SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY ASSESSMENT OF FELLOW EYES IN COATS DISEASE. Retina. 2017 Dec 15. doi: 10.1097/IAE.0000000000001995. [Epub ahead of print] PubMed PMID: 29252973
  11. Stringa F, Tsamis E, Papayannis A, Chwiejczak K, Jalil A, Biswas S, Ahmad H, Stanga PE. Segmented swept source optical coherence tomography angiography assessment of the perifoveal vasculature in patients with X-linked juvenile etinoschisis: a serial case report. Int Med Case Rep J. 2017 Oct 11;10:329-335
  12. Stanga PE, Pastor-Idoate S, Zambrano I, Carlin P, McLeod D. Performance analysis of a new hypersonic vitrector system. PLoS One. 2017 Jun 6;12(6):e0178462. doi: 10.1371/journal.pone.0178462. eCollection 2017
  13. Jones NP, Sala-Puigdollers A, Stanga PE. Ultra-widefield fundus fluorescein angiography in the diagnosis and management of retinal vasculitis. Eye (Lond). 2017 Nov;31(11):1546-1549
  14. Mills JO, Jalil A, Stanga PE. Electronic retinal implants and artificial vision: journey and present. Eye (Lond). 2017 Oct;31(10):1383-1398
  15. Pastor-Idoate S, Bonshek R, Irion L, Zambrano I, Carlin P, Mironov A, Bishop P, McLeod D, Stanga PE. Ultrastructural and histopathologic findings after pars plana vitrectomy with a new hypersonic vitrector system. Qualitative preliminary assessment. PLoS One. 2017 Apr 11;12(4)
  16. Duncan JL, Richards TP, Arditi A, da Cruz L, Dagnelie G, Dorn JD, Ho AC, Olmos de Koo LC, Barale PO, Stanga PE, Thumann G, Wang Y, Greenberg RJ. Improvements in vision-related quality of life in blind patients implanted with the Argus II Epiretinal Prosthesis. Clin Exp Optom. 2017 Mar;100(2):144-150
  17. Dagnelie G, Christopher P, Arditi A, da Cruz L, Duncan JL, Ho AC, Olmos de Koo LC, Sahel JA, Stanga PE, Thumann G, Wang Y, Arsiero M, Dorn JD, Greenberg RJ; Argus® II Study Group. Performance of real-world functional vision tasks by blind subjects improves after implantation with the Argus® II retinal prosthesis system. Clin Exp Ophthalmol. 2017 Mar;45(2):152-159
  18. da Cruz L, Dorn JD, Humayun MS, Dagnelie G, Handa J, Barale PO, Sahel JA, Stanga PE, Hafezi F, Safran AB, Salzmann J, Santos A, Birch D, Spencer R, Cideciyan AV, de Juan E, Duncan JL, Eliott D, Fawzi A, Olmos de Koo LC, Ho AC, Brown G, Haller J, Regillo C, Del Priore LV, Arditi A, Greenberg RJ; Argus II Study Group. Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial. Ophthalmology. 2016 Oct;123(10):2248-54
  19. Stanga PE, Papayannis A, Tsamis E, Stringa F, Cole T, D’Souza Y, Jalil A. New Findings in Diabetic Maculopathy and Proliferative Disease by Swept-Source Optical Coherence Tomography Angiography. Dev Ophthalmol. 2016;56:113-21
  20. Stanga PE, Papayannis A, Tsamis E, Chwiejczak K, Stringa F, Jalil A, Cole T, Biswas S. Swept-Source Optical Coherence Tomography Angiography of Paediatric Macular Diseases. Dev Ophthalmol. 2016;56:166-73
  21. Stanga PE, Tsamis E, Papayannis A, Stringa F, Cole T, Jalil A. Swept-Source Optical Coherence Tomography Angio™ (Topcon Corp, Japan): Technology Review. Dev Ophthalmol. 2016;56:13-7
  22. Geruschat DR, Richards TP, Arditi A, da Cruz L, Dagnelie G, Dorn JD, Duncan JL, Ho AC, Olmos de Koo LC, Sahel JA, Stanga PE, Thumann G, Wang V, Greenberg RJ. An analysis of observer-rated functional vision in patients implanted with the Argus II Retinal Prosthesis System at three years. Clin Exp Optom. 2016 May;99(3):227-32
  23. Stanga PE, Jaberansari H, Bindra MS, Gil-Martinez M, Biswas S. Transcleral Drainage of subretinal fluid, anti-vascular endothelial growth factor, and Wide-field imaging-guided laser in coats exudative retinal detachment. Retina. 2016 Jan;36(1):156-62
  24. Ho AC, Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Handa J, Barale PO, Sahel JA, Stanga PE, Hafezi F, Safran AB, Salzmann J, Santos A, Birch D, Spencer R, Cideciyan AV, de Juan E, Duncan JL, Eliott D, Fawzi A, Olmos de Koo LC, Brown GC, Haller JA, Regillo CD, Del Priore LV, Arditi A, Geruschat DR, Greenberg RJ; Argus II Study Group. Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind. Ophthalmology. 2015 Aug;122(8):1547-54
  25. Pastor-Idoate S, Gil-Martinez M, Crim N, Quijano C, Biswas S, Charles S, McLeod D, Stanga PE. Swept-source optical coherence tomography of retinal cavernous hemangioma: a new imaging modality. J Pediatr Ophthalmol Strabismus. 2015 Mar 4;52
  26. Tanawade RG, Muqit MM, McLeod D, Stanga PE. Swept-source optical coherence tomography imaging in conservative and surgical management of premacular haemorrhages showing inflammatory response. Clin Exp Ophthalmol. 2015 Jan-Feb;43(1):77-9
  27. Vaidya A, Borgonovi E, Taylor RS, Sahel JA, Rizzo S, Stanga PE, Kukreja A, Walter P. The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentos a patients. BMC Ophthalmol. 2014 Apr 14;14:49
  28. Muqit MM, Stanga PE. Swept-source optical coherence tomography imaging of the cortical vitreous and the vitreoretinal interface in proliferative diabetic retinopathy: assessment of vitreoschisis, neovascularisation and the internal limiting membrane. Br J Ophthalmol. 2014 Jul;98(7):994-7
  29. Stanga PE, Sala-Puigdollers A, Caputo S, Jaberansari H, Cien M, Gray J, D’Souza Y, Charles SJ, Biswas S, Henson DB, McLeod D. In vivo imaging of cortical vitreous using 1050-nm swept-source deep range imaging optical coherence tomography. Am J Ophthalmol. 2014 Feb;157(2):397-404
  30. Wang Y, Muqit MM, Stanga PE, Young LB, Henson DB. Spatial changes of central  field loss in diabetic retinopathy after laser. Optom Vis Sci. 2014 Jan;91(1):111-20
  31. Muqit MM, Stanga PE. Fourier-domain optical coherence tomography evaluation of retinal and optic nerve head neovascularisation in proliferative diabetic retinopathy. Br J Ophthalmol. 2014 Jan;98(1):65-72 Erratum in: Br J Ophthalmol. 2014 May;98(5):713
  32. Lanzetta P, Holz F, Monés J, Querques G, Stanga P, Veritti D, Barbone F, Brusaferro S, Isola M. Intravitreal injections: a healthcare failure modes and effects analysis. Ophthalmologica. 2013;230(3):151-64
  33. da Cruz L, Coley BF, Dorn J, Merlini F, Filley E, Christopher P, Chen FK, Wuyyuru V, Sahel J, Stanga P, Humayun M, Greenberg RJ, Dagnelie G; Argus II Study Group. The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss. Br J Ophthalmol. 2013 May;97(5):632-6. doi: 10.1136/bjophthalmol-2012-301525
  34. Ghanchi F; Diabetic Retinopathy Guidelines Working Group. The Royal College of Ophthalmologists’ clinical guidelines for diabetic retinopathy: a summary. Eye (Lond). 2013 Feb;27(2):285-7
  35. Muqit MM, Young LB, McKenzie R, John B, Marcellino GR, Henson DB, Turner GS, Stanga PE. Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study. Br J Ophthalmol. 2013 Feb;97(2):220-7
  36. Barry MP, Dagnelie G; Argus II Study Group. Use of the Argus II retinal prosthesis to improve visual guidance of fine hand movements. Invest Ophthalmol Vis Sci. 2012 Aug 1;53(9):5095-101
  37. Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Sahel JA, Stanga PE, Cideciyan AV, Duncan JL, Eliott D, Filley E, Ho AC, Santos A, Safran AB, Arditi A, Del Priore LV, Greenberg RJ; Argus II Study Group. Interim results from the international trial of Second Sight’s visual prosthesis. Ophthalmology. 2012 Apr;119(4):779-88
  38. Muqit MM, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Stanga PE. Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy. Acta Ophthalmol. 2013 May;91(3):251-8
  39. Muqit MK, Stanga PE, Vilar FJ, Patton N. Presumed entecavir-induced ocular toxicity. Eye (Lond). 2011 Dec;25(12):1665-8
  40. Muqit MM, Marcellino GR, Henson DB, Young LB, Turner GS, Stanga PE. Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4. Eye (Lond). 2011 Nov;25(11):1447-56
  41. Stanga PE, Muqit MM, Marcellino GR. Microstructural changes following inadvertent multi-spot laser photocoagulation of the fovea. Graefes Arch Clin Exp Ophthalmol. 2012 Jun;250(6):945-7
  42. Muqit MM, Marcellino GR, Henson DB, Fenerty CH, Stanga PE. Randomized clinical trial to evaluate the effects of Pascal panretinal photocoagulation on macular nerve fiber layer: Manchester Pascal Study report 3. Retina. 2011 Sep;31(8):1699-707
  43. Muqit MM, Akram I, Turner GS, Stanga PE. Fourier-domain optical coherence tomography imaging of gas tamponade following macular hole surgery. Ophthalmic Surg Lasers Imaging. 2010 Dec 1;41 Online:e1-6
  44. Nourrit V, Denniss J, Muqit MM, Schiessl I, Fenerty C, Stanga PE, Henson DB. High-resolution hyperspectral imaging of the retina with a modified fundus camera. J Fr Ophtalmol. 2010 Dec;33(10):686-92
  45. Stanga PE, Muqit MM. Re: Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser. Retina. 2010 Nov-Dec;30(10):1749-50; author reply 1750-1
  46. Muqit MM, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Stanga PE, Marcellino GR. Laser tissue interactions. Ophthalmology. 2010 Oct;117(10):2039
  47. Ahuja AK, Dorn JD, Caspi A, McMahon MJ, Dagnelie G, Dacruz L, Stanga P, Humayun MS, Greenberg RJ; Argus II Study Group. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. Br J Ophthalmol. 2011 Apr;95(4):539-43
  48. Muqit MM, Denniss J, Nourrit V, Marcellino GR, Henson DB, Schiessl I, Stanga PE. Spatial and spectral imaging of retinal laser photocoagulation burns. Invest Ophthalmol Vis Sci. 2011 Feb 23;52(2):994-1002
  49. Biswas S, Funnell CL, Gray J, Bunting R, Lloyd IC, Stanga PE. Nidek MP-1microperimetry and Fourier domain optical coherence tomography (FD-OCT) in X linked retinoschisis. Br J Ophthalmol. 2010 Jul;94(7):949-50
  50. Muqit MM, Marcellino GR, Gray JC, McLauchlan R, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Stanga PE. Pain responses of Pascal 20 ms multi-spot and 100 ms single-spot panretinal photocoagulation: Manchester Pascal Study, MAPASS report 2. Br J Ophthalmol. 2010 Nov;94(11):1493-8
  51. Muqit MM, Gray JC, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ,  Turner GS, Stanga PE. Barely visible 10-millisecond pascal laser photocoagulation for diabetic macular edema: observations of clinical effect and burn localization. Am J Ophthalmol. 2010 Jun;149(6):979-986
  52. Muqit MM, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Stanga PE. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study. Arch Ophthalmol. 2010 May;128(5):525-33
  53. Wong YM, Jalil A, Mathews J, Stanga PE. Exudative retinal detachment following photodynamic therapy for retinal capillary hemangioma. Can J Ophthalmol. 2010 Jun;45(3):299-300. doi: 10.3129/i09-258
  54. Muqit MM, Gray JC, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Dick AD, Stanga PE. In vivo laser-tissue interactions and healing responses from 20- vs 100-millisecond pulse Pascal photocoagulation burns. Arch Ophthalmol. 2010 Apr;128(4):448-55
  55. Stanga PE, Muqit MM, Marcellino GR. Comment and reply on: Structural changes of the retina after laser photocoagulation in spectral domain optical coherence tomography. Curr Eye Res. 2010 Mar;35(3):255-6; author reply 257-8
  56. Stanga PE, Muqit MM. Retinal laser photocoagulation, anaesthesia, and pain responses. Eye (Lond). 2010 Aug;24(8):1415-6; author reply 1416-7
  57. Muqit MM, Sanghvi C, McLauchlan R, Delgado C, Young LB, Charles SJ, Marcellino GR, Stanga PE. Study of clinical applications and safety for Pascal® laser photocoagulation in retinal vascular disorders. Acta Ophthalmol. 2012 Mar;90(2):155-61
  58. Muqit MM, Akram I, Turner GS, Stanga PE. Fourier-domain optical coherence tomography imaging of gas tamponade following macular hole surgery. Ophthalmic Surg Lasers Imaging. 2010 Dec 1;41 Online:e1-6
  59. Muqit MM, Wakely L, Stanga PE, Henson DB, Ghanchi FD. Effects of conventional argon panretinal laser photocoagulation on retinal nerve fibre layer and driving visual fields in diabetic retinopathy. Eye (Lond). 2010 Jul;24(7):1136-42
  60. Harding SP, Tomlin K, Reeves BC, Langham J, Walker J, Carpenter J, Grieve R, Patton WP, Muldrew KA, Peto T, Chakravarthy U; Verteporfin Photodynamic Therapy Cohort Study Group. Verteporfin photodynamic therapy cohort study: report 1: effectiveness and factors influencing outcomes. Ophthalmology. 2009 Dec;116(12):e1-8
  61. Bhojwani R, Houtman AC, Stanga P, Bonshek R, Lloyd IC, Baildam E, Biswas S. Presumed early-onset sarcoidosis: a case of devastating ocular inflammation in an infant. J Pediatr Ophthalmol Strabismus. 2009 Jul-Aug;46(4):245-8
  62. Jalil A, Mercieca K, Chaudhry NL, Stanga PE. Choroidal nonperfusion with significant subretinal exudation after PDT of predominantly classic CNV: an OCT and FFA study. Eur J Ophthalmol. 2009 May-Jun;19(3):490-3
  63. Muqit MM, Gray JC, Marcellino GR, Henson DB, Young LB, Charles SJ, Turner GS, Stanga PE. Fundus autofluorescence and Fourier-domain optical coherence tomography imaging of 10 and 20 millisecond Pascal retinal photocoagulation treatment. Br J Ophthalmol. 2009 Apr;93(4):518-25
  64. Ziahosseini K, Sanghvi C, Muzaffar W, Stanga PE. Successful surgical treatment of optic disc pit maculopathy. Eye (Lond). 2009 Jun;23(6):1477-9
  65. Sanghvi C, McLauchlan R, Delgado C, Young L, Charles SJ, Marcellino G, Stanga PE. Initial experience with the Pascal photocoagulator: a pilot study of 75 procedures. Br J Ophthalmol. 2008 Aug;92(8):1061-4
  66. Mathews JP, Jalil A, Lavin MJ, Stanga PE. Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin): optical coherence tomography and fluorescein angiographic findings. Eye (Lond). 2007 Jul;21(7):1004-5
  67. Sahni J, Stanga P, Wong D, Lenfestey P, Kent D, Harding S. Optical coherence  tomography analysis of bilateral end-stage choroidal neovascularization where one eye is treated with photodynamic therapy. Clin Exp Ophthalmol. 2007 Jan-Feb;35(1):13-7
  68. Sikkink SK, Biswas S, Parry NR, Stanga PE, Trump D. X-linked retinoschisis: an update. J Med Genet. 2007 Apr;44(4):225-32
  69. Devadason DS, Mahmood S, Stanga PE, Bishop PN. Solar retinopathy in a patient with bipolar affective disorder. Br J Ophthalmol. 2006 Feb;90(2):247
  70. Rahman I, Saleemi G, Semple D, Stanga P. Pre-eclampsia resulting in central retinal vein occlusion. Eye (Lond). 2006 Aug;20(8):955-7
  71. Sahni J, Stanga P, Wong D, Harding S. Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study. Br J Ophthalmol. 2005 Mar;89(3):316-20
  72. Berra A, Ferreira S, Stanga P, Llesuy S. Age-related antioxidant capacity of the vitreous and its possible relationship with simultaneous changes in photoreceptors, retinal pigment epithelium and Bruchs’ membrane in human donors’ eyes. Arch Gerontol Geriatr. 2002 May-Jun;34(3):371-7
  73. Wong D, Stanga P, Briggs M, Lenfestey P, Lancaster E, Li KK, Lim KS, Groenewald C. Case selection in macular relocation surgery for age related macular degeneration. Br J Ophthalmol. 2004 Feb;88(2):186-90
  74. Stanga P, Hiscott P, Li K, Wong D. Macular relocation after photodynamic therapy for recurrent choroidal neovascular membrane: visual results and histopathological findings. Br J Ophthalmol. 2003 Aug;87(8):975-6
  75. Kabanarou SA, Holder GE, Bird AC, Webster AR, Stanga PE, Vickers S, Harney BA. Isolated foveal retinoschisis as a cause of visual loss in young females. Br J Ophthalmol. 2003 Jun;87(6):801-3
  76. Stappler T, Stanga P, Groenewald C, El Bably I, Wong D. Measurement of cyclotorsion in a patient following macular translocation surgery using a modified version of the Watzke-Allen test. Retina. 2003 Apr;23(2):250-2
  77. Li K, Wong D, Hiscott P, Stanga P, Groenewald C, McGalliard J. Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings. Br J Ophthalmol. 2003 Feb;87(2):216-9
  78. Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology. 2003 Jan;110(1):15-21; quiz 22-3
  79. Stanga PE, Kychenthal A, Fitzke FW, Halfyard AS, Chan R, Bird AC, Aylward GW. Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration. Ophthalmology. 2002 Aug;109(8):1492-8
  80. Stanga PE, Downes SM, Ahuja RM, Chong NH, Antcliff R, Reck AC, Bird AC. Comparison of optical coherence tomography and fluorescein angiography in assessing macular edema in retinal dystrophies: preliminary results. Int Ophthalmol. 2001;23(4-6):321-5
  81. Stanga PE, Kychenthal A, Fitzke FW, Halfyard AS, Chan R, Asaria RH, Bird AC, Aylward GW. Functional assessment of the native retinal pigment epithelium after the surgical excision of subfoveal choroidal neovascular membranes type II: preliminary results. Int Ophthalmol. 2001;23(4-6):309-16
  82. Stanga PE, Kychenthal A, Fitzke FW, Halfyard AS, Chan R, Bird AC, Aylward GW. Retinal pigment epithelium translocation and central visual function in age related macular degeneration: preliminary results. Int Ophthalmol. 2001;23(4-6):297-307
  83. Stanga PE, Bird AC. Optical coherence tomography (OCT): principles of operation, technology, indications in vitreoretinal imaging and interpretation of results. Int Ophthalmol. 2001;23(4-6):191-7
  84. Ahuja RM, Downes SM, Stanga PE, Koh AH, Vingerling JR, Bird AC. Polypoidal choroidal vasculopathy and central serous chorioretinopathy. Ophthalmology. 2001 Jun;108(6):1009-10
  85. Stanga PE, Chong NH, Reck AC, Hardcastle AJ, Holder GE. Optical coherence tomography and electrophysiology in X-linked juvenile retinoschisis associated with a novel mutation in the XLRS1 gene. Retina. 2001;21(1):78-80
  86. Ahuja RM, Stanga PE, Vingerling JR, Reck AC, Bird AC. Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments. Br J Ophthalmol. 2000 May;84(5):479-84
  87. Stanga PE, Reck AC, Hamilton AM. Micropulse laser in the treatment of diabetic macular edema. Semin Ophthalmol. 1999 Dec;14(4):210-3
  88. Stanga PE, Boyd SR, Hamilton AM. Ocular manifestations of diabetes mellitus. Curr Opin Ophthalmol. 1999 Dec;10(6):483-9
  89. Parmar DN, Stanga PE, Reck AC, Vingerling JR, Sullivan P. Imaging of a traumatic macular hole with spontaneous closure. Retina. 1999;19(5):470-2
  90. Lincoff H, Kreissig I, Gelisken F, Stanga P. A retained catheter for retrobulbar administration of interferon for age-related macular degeneration. Dev Ophthalmol. 1997;29:69-77
  91. Lincoff H, Stanga P, Movshovich A, Palleroni A, Madjarov B, Rivera R, Silverman R. Choroidal concentration of interferon after retrobulbar injection. Invest Ophthalmol Vis Sci. 1996 Dec;37(13):2768-71
  1. K. Li, D. Wong, P. Hiscott, P. E. Stanga, C. Groenewald, J. McGalliard. Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings. Br J Ophthalmol 2003;87(2):216-9
    First paper to establish the safety of Trypan blue staining of epiretinal and internal limiting membranes. The advent of this dye had a significant impact on the indications, ease of performance and percentage successful outcome of current vitreoretinal surgical techniques.
  2. P. E. Stanga, A. Kychenthal, F W. Fitzke, A. S. Halfyard, R. Chan, A. C. Bird, G. W. Aylward. Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration. Ophthalmol 2002;109(8):1492-8
    Benchmark paper as it reported for the first time the use of novel imaging techniques to show function in translocated retinal pigment epithelium (RPE) and reported a new surgical technique. This paper convincingly demonstrated for the first time the survival of translocated RPE cells and the function of overlying retina.
  3. P. Stanga, J. Lim, A. M. P. Hamilton. Indocyanine Green Angiography in Ocular Diseases; Indications and Interpretation – An Evidence-based Update (Review article). Ophthalmology 2003;110(1):15-21; quiz 22-3
    This review by invitation was the first paper to establish the available evidence based practice in the indication and interpretation of a novel imaging technique.
  4. R. M. Ahuja, P. Stanga, J. R. Vingerling, A. Reck, A.C. Bird. Polypoidal choroidopathy in patients with hemorrhagic and exudative pigment epithelial detachments Degeneration – Br J Opthalmol; 2000; 84: 0-5
    First British paper to establish prevalence of polypoidal choroidopathy. At the time innovative retinal imaging with indocyanine green angiography was performed. This paper had a significant impact on the diagnosis and treatment of age-related macular degeneration and influenced RCOpth guidelines.
  5. J. Sahni, P. Stanga, D. Wong, S. Harding. Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study. Br J Ophthalmol 2005;89:316-320
    This paper introduced new optical coherence tomography (OCT) terminology, validated its reliability for the analysis of OCT scans treatment of age-related macular degeneration and established its role in deciding re-retreatments. This technology is now sine qua non in retinal clinics across the world.
  1. Stanga PE, Papayannis A, Tsamis E, Stringa F, Cole T, D’Souza Y, Jalil A. New Findings in Diabetic Maculopathy and Proliferative Disease by Swept-Source Optical Coherence Tomography Angiography. Dev Ophthalmol. 2016;56:113-21. doi: 10.1159/000442802. Epub 2016 Mar 15. Review
  2. Stanga PE, Jaberansari H, Bindra MS, Gil-Martinez M, Biswas S. Transcleral Drainage of Subretinal Fluid, anti-Vascular Endothelial Growth Factor and Wide-Field Imaging-guided Laser in Coats Exudative Retinal Detachment. Retina. 2016 Jan;36(1):156-62
  3. Vaidya A, Borgonovi E, Taylor RS, Sahel JA, Rizzo S, Stanga PE, Kukreja A, Walter P. The cost- effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients. BMC Ophthalmol. 2014 Apr 14;14:49
  4. Stanga PE, Sala-Puigdollers A, Caputo S, Jaberansari H, Cien M, Gray J, D’Souza Y, Charles SJ, Biswas S, Henson DB, McLeod D. In vivo imaging of cortical vitreous using 1050-nm swept-source deep range imaging optical coherence tomography. Am J Ophthalmol. 2014 Feb;157(2):397-404. Epub 2013 Oct 22
  5. Muqit MM, Young LB, McKenzie R, John B, Marcellino GR, Henson DB, Turner GS, Stanga PE. Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study. Br J Ophthalmol. 2013 Feb;97(2):220-7. doi: 10.1136/bjophthalmol-2012-302189. Epub 2012 Nov 24
  1. Electronic Retinal Implants and Artificial Vision: Journey and Present, Mills J, Jalil A, Stanga P. EYE-16-1061R2016 In Press (2017)
    New Findings in Diabetic Maculopathy and Proliferative Disease by Swept-Source Optical Coherence Tomography Angiography
  2. Stanga PE, Papayannis A, Tsamis E, Stringa F, Cole T, D’Souza Y, Jalil A. Dev Ophthalmol. 2016;56:113-21. doi: 10.1159/000442802. Epub 2016 Mar 15. Review. PMID: 27023703
  3. Swept-Source Optical Coherence Tomography Angiography of Paediatric Macular Diseases. Stanga PE, Papayannis A, Tsamis E, Chwiejczak K, Stringa F, Jalil A, Cole T, Biswas S. Dev Ophthalmol. 2016;56:166-73. doi: 10.1159/000442809. Epub 2016 Mar 15. Review. PMID: 27023179
  4. Swept-Source Optical Coherence Tomography AngioTM (Topcon Corp, Japan): Technology Review. Stanga PE, Tsamis E, Papayannis A, Stringa F, Cole T, Jalil A. Dev Ophthalmol. 2016;56:13-7. doi: 10.1159/000442771. Epub 2016 Mar 15. Review. PMID: 27023108
  5. Intravitreal injections: a healthcare failure modes and effects analysis. Lanzetta P, Holz F, Monés J, Querques G, Stanga P, Veritti D, Barbone F, Brusaferro S, Isola M. Ophthalmologica. 2013;230(3):151-64. doi: 10.1159/000354549. Epub 2013 Aug 31. PMID: 24008511
  6. X-linked retinoschisis: an update. Sikkink SK, Biswas S, Parry NR, Stanga PE, Trump D. J Med Genet. 2007 Apr;44(4):225-32. Epub 2006 Dec 15. Review. PMID: 17172462
  7. Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Stanga PE, Lim JI, Hamilton P. Ophthalmology. 2003 Jan;110(1):15-21; quiz 22-3. Review. PMID: 12511340
  8. Optical coherence tomography (OCT): principles of operation, technology, indications in vitreoretinal imaging and interpretation of results. Stanga PE, Bird AC. Int Ophthalmol. 2001;23(4-6):191-7. Review. No abstract available. PMID: 11944840
  9. Ocular manifestations of diabetes mellitus. Stanga PE, Boyd SR, Hamilton AM. Curr Opin Ophthalmol. 1999 Dec;10(6):483-9. Review. PMID: 10662255
    RCOph Guidelines (1)
  10. The Royal College of Ophthalmologists’ clinical guidelines for diabetic retinopathy: a summary. Diabetic Retinopathy Guidelines Working Group. Eye (Lond). 2013 Feb;27(2):285-7. doi: 10.1038/eye.2012.287. Epub 2013 Jan 11
  1. New Findings in Diabetic Maculopathy and Proliferative Disease by Swept-Source Optical Coherence Tomography Angiography. Stanga PE, Papayannis A, Tsamis E, Stringa F, Cole T, D’Souza Y, Jalil A. Dev Ophthalmol. 2016;56:113-21. doi: 10.1159/000442802. Epub 2016 Mar 15 PMID: 27023703
  2. Swept-Source Optical Coherence Tomography Angiography of Paediatric Macular
    Diseases. Stanga PE, Papayannis A, Tsamis E, Chwiejczak K, Stringa F, Jalil A, Cole T, Biswas S. Dev Ophthalmol. 2016;56:166-73. doi: 10.1159/000442809. Epub 2016 Mar 15. PMID: 27023179
  3. Swept-Source Optical Coherence Tomography AngioTM (Topcon Corp, Japan): Technology Review. Stanga PE, Tsamis E, Papayannis A, Stringa F, Cole T, Jalil A. Dev Ophthalmol. 2016;56:13-7. doi: 10.1159/000442771. Epub 2016 Mar 15. PMID: 27023108
  1. Books: Regulations for the Diagnosis and Therapy of Eye Diseases – ISBN: 950-16-6901-7, 1st. Ed., 1995

Schedule your private consultation

Clinical Trials -
Currently Recruiting Patients

FIND OUT MORE
  • Find Us

140 Harley Street, Ground Floor, London, W1G 7LB, United Kingdom

  • Call Us

+44(0)20 4548 5310

BOOK A CONSULTATION
GET IN TOUCH
BOOK A CONSULTATION
GET IN TOUCH

Stanga Ltd trading as “The Retina Clinic London” Company number: 4840976. The Retina Clinic London, Ground Floor, 140 Harley Street, London, W1G 7LB, United Kingdom. Designed & Build by The Agency Creative.